KPTI Stock Summary and Trading Ideas (Karyopharm Therapeutics | NASDAQ:KPTI)

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

What symbol and exchange does Karyopharm Therapeutics shares trade?

Karyopharm Therapeutics trades on the NASDAQ stock market under the symbol KPTI.

What is Karyopharm Therapeutics stock price doing today?

As of June 5, 2026, KPTI stock price climbed to $9.08 with 257,913 million shares trading.

What is Karyopharm Therapeutics's Beta?

KPTI has a beta of 2.38, meaning it tends to be more sensitive to market movements. KPTI has a correlation of 0.09 to the broad based SPY ETF.

How much is Karyopharm Therapeutics worth?

KPTI has a market cap of $205.78 million. This is considered a Small Cap stock.

How much money does Karyopharm Therapeutics make?

Last quarter Karyopharm Therapeutics reported $35 million in Revenue and -$1.24 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.20.

What is the highest and lowest price Karyopharm Therapeutics traded in the last 3 year period?

In the last 3 years, KPTI traded as high as $37.05 and as low as $3.51.

What are the top ETFs holding Karyopharm Therapeutics?

The top ETF exchange traded funds that KPTI belongs to (by Net Assets): VTI, VXF, IWC, PRFZ.

Is Karyopharm Therapeutics (KPTI) a good investment?

KPTI has outperformed the market in the last year with a price return of +113.1% while the SPY ETF gained +25.6%. However, in the short term, KPTI had mixed performance relative to the market. It has underperformed in the last 3 months, returning +2.9% vs +8.5% return in SPY. But in the last 2 weeks, KPTI shares have fared better than the market returning +11.3% compared to SPY -1.1%.

What are the support and resistance levels for Karyopharm Therapeutics (KPTI)?

KPTI support price is $8.46 and resistance is $9.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KPTI shares will trade within this expected range on the day.